E-LIB Suche - Ergebnisse für: Vaishampayan, U.

1

Patients experience with recurrence of renal cell carcinoma:

Rodler, S. ; Goetz, M. ; Graser, A....
European Urology. 83 (2023) - p. S681 , 2023

Link: https://doi.org/10.1016/..

2

First-in-human phase 1 study of the anti-TIGIT antibody vib..:

Niu, J. ; Maurice-Dror, C. ; Lee, D.H....
Annals of Oncology. 33 (2022) 2 - p. 169-180 , 2022

Link: https://doi.org/10.1016/..

3

Subasumstat, a first-in-class inhibitor of SUMO-activating ..:

Saggu, G. ; Stroopinsky, D. ; Dudek, A.Z....
European Journal of Cancer. 174 (2022) - p. S125-S126 , 2022

Link: https://doi.org/10.1016/..

4

Impact of contemporary patterns of chemotherapy utilization..:

Bamias, A. ; Tzannis, K. ; Harshman, L.C....
Annals of Oncology. 30 (2019) 11 - p. 1841 , 2019

Link: https://doi.org/10.1093/..

5

FIERCE-21: Phase 2 study of vofatamab (B-701), a selective ..:

Necchi, A. ; Castellano, D. ; Mellado, B....
European Urology Supplements. 18 (2019) 1 - p. e1513 , 2019

Link: https://doi.org/10.1016/..

6

PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PAT..:

Huynh, L. ; Wells, J.C. ; Graham, J....
Value in Health. 22 (2019) - p. S59-S60 , 2019

Link: https://doi.org/10.1016/..

7

Impact of number of cycles of platinum-based first-line che..:

Necchi, A. ; Mariani, L. ; Lo Vullo, S....
European Urology Supplements. 17 (2018) 2 - p. e131-e132 , 2018

Link: https://doi.org/10.1016/..

8

Nomogram-based risk prediction of local and distant relapse..:

Raggi, D. ; Pond, G. ; Giannatempo, P....
European Urology Supplements. 17 (2018) 2 - p. e519-e520 , 2018

Link: https://doi.org/10.1016/..

9

Pattern of relapse after perioperative chemotherapy and rad..:

Necchi, A. ; Pond, G. ; Plimack, E....
European Urology Supplements. 16 (2017) 10 - p. e2794-e2795 , 2017

Link: https://doi.org/10.1016/..

10

A PHASE 1 STUDY OF BET INHIBITION USING RG6146 IN RELAPSED/..:

Caimi, P.F. ; Eder, J.P. ; Jacobsen, E.D....
Hematological Oncology. 35 (2017) S2 - p. 263-265 , 2017

Link: https://doi.org/10.1002/..

11

A phase 1/2 open-label study of safety and antitumor activi..:

Attard, G. ; Montgomery, R. ; Vaishampayan, U....
European Urology Supplements. 15 (2016) 13 - p. e1645-e1646 , 2016

Link: https://doi.org/10.1016/..

12

A first-in-human phase I study to evaluate the ERK1/2 inhib..:

Varga, A. ; Soria, J.C. ; Hollebecque, A....
European Journal of Cancer. 69 (2016) - p. S11 , 2016

Link: https://doi.org/10.1016/..

13

2619 Patterns and potential benefit of adjuvant chemotherap..:

Harshman, L. ; Werner, L. ; Wong, Y.N....
European Journal of Cancer. 51 (2015) - p. S518 , 2015

Link: https://doi.org/10.1016/..

14

2607 Predicting venous thromboembolism (VTE) in metastatic ..:

Ramos, J. ; Casey, M. ; Bamias, A....
European Journal of Cancer. 51 (2015) - p. S514 , 2015

Link: https://doi.org/10.1016/..

15

7 Characterizing the impact of lymph node metastases on sur..:

Kröger, N. ; Pantuck, A. ; Wells, C....
European Urology Supplements. 14 (2015) 2 - p. e7-e7a , 2015

Link: https://doi.org/10.1016/..